Short Interest in BioNexus Gene Lab Corp. (NASDAQ:BGLC) Drops By 36.2%

BioNexus Gene Lab Corp. (NASDAQ:BGLC) was the recipient of a significant decline in short interest in March. As of March 15th, there was short interest totalling 233,600 shares, a decline of 36.2% from the February 28th total of 366,100 shares. Based on an average daily volume of 3,480,000 shares, the short-interest ratio is presently 0.1 days. Approximately 2.1% of the company’s stock are short sold.

BioNexus Gene Lab Trading Down 6.8 %

BioNexus Gene Lab stock opened at $0.23 on Monday. BioNexus Gene Lab has a 52-week low of $0.21 and a 52-week high of $1.00. The company’s 50 day moving average is $0.35 and its two-hundred day moving average is $0.35.

About BioNexus Gene Lab

BioNexus Gene Lab Corp., through its subsidiary, sells chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company offers chemical raw material products, which include Polyester Resin SHCP 268, a thixotropic, quick-curing unsaturated polyester resin suitable as a general-purpose resin; Polyester Resin 9509, a general-purpose material used in production of marine boats and water slides; and Polyester Resin 2802 used as a component in the pultrusion process by certain manufacturers.